Tricyclic antidepressants (TCAs) are a class of older-generation medications primarily used to treat major depressive disorder, certain anxiety disorders, chronic pain syndromes, neuropathic pain, migraine prophylaxis, insomnia, and obsessive-compulsive disorder. They work by inhibiting the reuptake of norepinephrine and serotonin at presynaptic neurons, thereby increasing the availability of...

"Executive Summary Tricyclic antidepressants Market Size and Share Analysis Report Data Bridge Market Research analyses a growth rate in the global tricyclic antidepressants market in the forecast period 2022-2029. The expected CAGR of global tricyclic antidepressants market is tend to be around 7.80% in the mentioned forecast period. the Tricyclic antidepressants Market analysis report,...